194 related articles for article (PubMed ID: 20812879)
1. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
Emir B; Murphy TK; Petersel DL; Whalen E
Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
[TBL] [Abstract][Full Text] [Related]
2. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
[TBL] [Abstract][Full Text] [Related]
3. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
Arnold LM; Leon T; Whalen E; Barrett J
Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
[TBL] [Abstract][Full Text] [Related]
4. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
[TBL] [Abstract][Full Text] [Related]
5. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
[TBL] [Abstract][Full Text] [Related]
6. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
9. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
11. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.
Russell IJ; Crofford LJ; Leon T; Cappelleri JC; Bushmakin AG; Whalen E; Barrett JA; Sadosky A
Sleep Med; 2009 Jun; 10(6):604-10. PubMed ID: 19410509
[TBL] [Abstract][Full Text] [Related]
12. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arnold LM; Goldenberg DL; Stanford SB; Lalonde JK; Sandhu HS; Keck PE; Welge JA; Bishop F; Stanford KE; Hess EV; Hudson JI
Arthritis Rheum; 2007 Apr; 56(4):1336-44. PubMed ID: 17393438
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin.
Bushmakin AG; Cappelleri JC; Chandran AB; Zlateva G
Int J Clin Pract; 2013 Jan; 67(1):52-9. PubMed ID: 23241048
[TBL] [Abstract][Full Text] [Related]
15. Pregabalin: a treatment for fibromyalgia and other painful conditions.
Smith SM
Nurs Womens Health; 2008 Oct; 12(5):432-5. PubMed ID: 18837723
[No Abstract] [Full Text] [Related]
16. Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials.
Bhadra P; Petersel D
Expert Opin Pharmacother; 2010 Dec; 11(17):2805-12. PubMed ID: 21039311
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin for fibromyalgia: some relief but no cure.
Kim L; Lipton S; Deodhar A
Cleve Clin J Med; 2009 Apr; 76(4):255-61. PubMed ID: 19339642
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
Straube S; Derry S; Moore RA; McQuay HJ
Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
[TBL] [Abstract][Full Text] [Related]
20. Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results.
Cappelleri JC; Bushmakin AG; Zlateva G; Sadosky A
Pain Pract; 2009; 9(5):348-53. PubMed ID: 19549060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]